“Oncology Meeting Innovations’ (OMI’s) Virtual Regional Summit on B-cell Malignancies assembles community physicians in a 3-hour program in which KOLs will present their current approaches to B-cell malignancies.  Topics include Optimising Ibrutinib Therapy for Patients with CLL, Targeted Approaches to Follicular Lymphoma, Expanding the Use of CAR-T Therapy in B-cell NHL, and Current Approaches to Ibrutinib Therapy in WM.  Attendees will have the opportunity after each presentation to pose questions of KOL presenters and receive their recommendations on how to approach current treatment challenges.”